Dupilumab reduces pruritus, anxiety, depression in atopic dermatitis
18 May 2020
byRoshini Claire Anthony
Post hoc analyses of the LIBERTY AD SOLO 1 & 2* and ADOL** trials demonstrated significant reductions in pruritus, anxiety, and depression with dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD).
Dupilumab reduces pruritus, anxiety, depression in atopic dermatitis
18 May 2020